This website uses cookies – small text files stored on your device, when you visit a website – including third party cookies to collect information about your browsing activities and improve the content, functionality and performance of our website. Out of these cookies, the cookies that are categorized as Necessary Cookies are stored on your browser as they are essential for the operation of the website. You may accept all cookies, or reject all cookies other than Necessary Cookies. If you visit us from a different device or browser, or clear cookies, then you may need to return to this screen to re-select your preferences. Note that rejecting some of these cookies may have an effect on your browsing experience. Please note that if you do not make a selection below, only necessary cookies will be set....
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Other cookies are those that are being identified and have not been classified into any category as yet.
New Executive Order Seeks to Combat “Overcriminalization in Federal Regulations”
Gibson Dunn is monitoring regulatory developments and executive orders closely. Our attorneys are available to assist clients as they navigate the challenges and opportunities posed by the current, evolving legal landscape.
Derivatives, Legislative and Regulatory Weekly Update (May 16, 2025)
Gibson Dunn’s lawyers bring you the latest in U.S. derivatives news from the past week.
John Partridge Discusses Whistleblowing and Shifting Corporate Enforcement Priorities with Agenda
Partner and Co-Chair of our FDA and Health Care Practice Group, John Partridge, recently spoke to the Financial Times’ Agenda (subscription required) about the importance of maintaining strong internal reporting programs — even as corporate enforcement priorities shift.
Gibson Dunn Earns Litigator of the Week Shout-Out for Rare Complete Summary Win in Harassment Case
A Gibson Dunn team earned a Litigator of the Week shout-out from Litigation Daily for securing a rare complete summary judgment win on behalf of our client, GRAIL, Inc., against a former employee’s claims of race-based discrimination, harassment, and retaliation under the California Fair Employment and Housing Act
In the May episode of the Bloomberg Intelligence FICC Focus podcast, partner and Global Chair of our Business Restructuring and Reorganization Practice Group, Scott Greenberg, joins Bloomberg’s Negisa Balluku to discuss his extensive involvement in the liability management space and share his unique insight into the evolution of lender cooperation agreements.
Gibson Dunn represented the initial purchasers in Alliant Energy Corporation’s (AEC) private offering of $575 million aggregate principal amount of 3.250% convertible senior notes due 2028
